Newsletter | September 9, 2024

09.09.24 -- Optimize Your Confidentiality Disclosure Agreement Process

A Streamlined Process For Mutual Confidentiality Disclosure Agreements

A confidentiality disclosure agreement (CDA) is necessary to facilitate a confidential framework between a client and CDMO, allowing a free exchange of information. However, disparities in CDA templates, out-of-date language, agreements involving more than two parties, and difficulty in gathering necessary signatures all can derail this critical process.

 

Real-Time Monitoring Of Pharmaceutical Shipments

High value and/or highly sensitive pharmaceutical products require advanced logistics consideration to maintain product quality. Supply chain visibility is paramount to ensure the success of your shipping program. Review what criteria should be considered when evaluating monitoring devices whose data can be accessed from the provider’s software platform in real-time.

 

OPCU VIDEO FEATURE

Capacity Update May 2024: Large Molecule Development

This presentation covers approaches being used at Singota Solutions to assess programs’ status quo and the desired outcomes. Review analytical, product and process development, and manufacturing capabilities along with the tools deployed to create sponsor’s clinical materials supply, and the knowledge required to demonstrate product and process understanding.

 

IN THE NEWS

Singota Solutions Unveils Strategic Approaches For Accelerating Drug Product Supply At Second Annual Capacity And Capability Update

Singota's Goal Of Celebrating And Expanding Women In STEM

Expanding Our Analytical Capabilities To Include HPLC/Mass Spectrometry